Principal Financial Group
ASND icon

Principal Financial Group’s Ascendis Pharma A/S ASND Stock Holding History

Principal Financial Group’s Portfolio ASND Stock Details ASND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$233M Sell
873,502
-22,895
-3% -$5.35M 0.11% 172
2026
Q1 		$205M Sell
896,397
-130,010
-13% -$29.1M 0.11% 176
2025
Q4 		$219M Buy
1,026,407
+232,730
+29% +$48.1M 0.11% 170
2025
Q3 		$158M Buy
793,677
+765,561
+2,723% +$143M 0.08% 211
2025
Q2 		$4.85M Buy
+28,116
New +$4.58M ﹤0.01% 1586

Other funds holding ASND

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Principal Financial Group's ASND Position: Q2 2026 in Review

Principal Financial Group reduced its Ascendis Pharma A/S (ASND) stake by 2.6% in Q2 2026, selling an estimated $5.35M and leaving 873,502 shares worth $233M. The position accounts for 0.11% of the portfolio, ranked #172.

Principal Financial Group first reported a position in ASND in Q2 2025 and has held it in 5 quarters since. 311 funds tracked by Wall St. Rank hold ASND as of Q2 2026.

  • Principal Financial Group held 873,502 shares of Ascendis Pharma A/S worth $233M as of Q2 2026.
  • Principal Financial Group sold 22,895 Ascendis Pharma A/S shares in Q2 2026, an estimated $5.35M.
  • Ascendis Pharma A/S made up 0.11% of Principal Financial Group's portfolio in Q2 2026, its #172 holding.
  • Principal Financial Group first reported a position in Ascendis Pharma A/S in Q2 2025 and has held it in 5 quarters since.
  • 311 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2026.

Based on Principal Financial Group's 13F filing for Q2 2026, filed 4 Aug 2026.